Hypoglycemia in horses refers to abnormally low blood glucose levels that can disrupt normal cellular function and, when severe, constitute a life-threatening metabolic emergency. Glucose serves as the primary energy source for many tissues, most critically the brain, which has limited ability to utilize alternative fuel sources and is therefore particularly vulnerable to glucose deprivation. In horses, hypoglycemia occurs most commonly in neonatal foals but can also affect adult horses under certain pathological conditions. The condition requires prompt recognition and treatment to prevent neurological damage, organ dysfunction, and potentially fatal outcomes.
Hypoglycemia predominantly affects neonatal foals during the first days to weeks of life, making it a significant concern in foal care and neonatal medicine. Newborn foals have limited glycogen stores and high metabolic rates, making them dependent on regular nursing for glucose intake. Premature, dysmature, or sick foals are at particularly high risk due to reduced reserves, impaired nursing ability, or increased metabolic demands. Sepsis represents a major cause of hypoglycemia in foals, as systemic infection dramatically increases glucose consumption while potentially impairing glucose production. Adult horses rarely develop true hypoglycemia except in the context of severe liver disease, certain tumors, or extreme conditions of starvation or metabolic crisis.
The impact of hypoglycemia on equine health depends on its severity and duration. The brain is exquisitely sensitive to glucose deprivation, and hypoglycemia produces progressive neurological signs ranging from mild weakness and lethargy to seizures, coma, and death. Glucose is also essential for normal function of most other organ systems, and prolonged hypoglycemia can cause widespread cellular dysfunction. In foals, hypoglycemia may compound other aspects of neonatal illness, contributing to poor outcomes in already compromised patients. Even when successfully treated, severe or prolonged hypoglycemia may result in lasting neurological damage.
The treatability of hypoglycemia is generally good when the condition is recognized quickly and appropriate glucose supplementation is provided. Intravenous dextrose administration can rapidly restore blood glucose levels and reverse clinical signs in many cases. However, treatment must address not only the immediate glucose deficit but also the underlying cause of hypoglycemia to prevent recurrence and achieve lasting improvement. In foals, this often means treating concurrent conditions such as sepsis while ensuring adequate nutritional intake. The prognosis for hypoglycemia depends heavily on the underlying cause, with isolated hypoglycemia from poor nursing carrying a better prognosis than hypoglycemia secondary to severe sepsis or organ failure.
